| Patents for A61P 3 - Drugs for disorders of the metabolism (129,789) |
|---|
| 05/21/1997 | CN1150034A 一种治疗"中消"型糖尿病的糖脂克药物组合物 A method of treating "the consumer" diabetes glycolipids gram pharmaceutical compositions |
| 05/21/1997 | CN1034938C Process for preparing 4H-naphtho [1,2-b] pyran compound |
| 05/21/1997 | CA2190822A1 Potassium predominant bicarbonate mixture for neutralizing acidic body wastes |
| 05/21/1997 | CA2190693A1 Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 05/21/1997 | CA2190692A1 Substituted benzenedicarboxylic acid diguanides, process for their preparation, their use as a medicament or diagnostic, and medicament containing them |
| 05/21/1997 | CA2190560A1 Process for producing vitamin d3 derivatives |
| 05/20/1997 | US5631373 Alkyl, azido, alkoxy, and fluoro-substituted and fused quinoxalinediones |
| 05/20/1997 | US5631369 Process for preparing benzoic acid derivative intermediates and benzothiophene pharmaceutical agents |
| 05/20/1997 | US5631365 Hydroxy-substituted azetidinone compounds useful as hypocholesterolemic agents |
| 05/20/1997 | US5631326 Crosslinked nitrogen-containing vinyl copolymers processes for their preparation and the use of these compounds |
| 05/20/1997 | US5631293 Cardiovascular disorders |
| 05/20/1997 | US5631289 Treatment of calcium deficiency and reducing irritation in intestines |
| 05/20/1997 | US5631263 Use of delta opioid receptor antagonists to treat immunoregulatory disorders |
| 05/20/1997 | US5631260 Xanthine epoxides as A1 adenosine receptor agonists and antagonists |
| 05/20/1997 | US5631247 Antilipemic agents, cardiovascular disorders, urogenital disorders and osteoporosis |
| 05/20/1997 | US5631224 Use of a peptide |
| 05/20/1997 | US5631009 Erythrocytes and reaction with antisera and antibodies |
| 05/20/1997 | CA2112355C Improved process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hyperglycemia in vertebrates |
| 05/20/1997 | CA2019841C 4,5-dihydro-6h-imidazo[4,5,1-ij]quinolin-6-one-6- oxime-o-sulfonic acid derivatives |
| 05/15/1997 | WO1997017446A2 HUMANIZED ANTIBODIES TO HUMAN gp39, COMPOSITIONS CONTAINING AND THERAPEUTIC USE THEREOF |
| 05/15/1997 | WO1997017067A1 Sublingual and buccal administration of selegiline |
| 05/15/1997 | CA2190220A1 Sulfonylamino-substituted benzoylguanidines, a process for their preparation, their use as medicament of diagnostic aid, and medicament containing them |
| 05/14/1997 | EP0773226A1 Propiophenone derivative and processes for preparing the same |
| 05/14/1997 | EP0773019A1 Hyperlipemia remedy |
| 05/14/1997 | EP0772606A1 Substituted thiazoles for the treatment of inflammation |
| 05/14/1997 | EP0772585A1 Aryloxy and arylthiopropanolamine derivatives useful as beta 3-adrenoreceptor agonists and antagonists of the beta 1 and beta 2-adrenoreceptors and pharmaceutical composition thereof |
| 05/14/1997 | EP0772451A1 Treatment of type ii diabetes mellitus with amylin agonists |
| 05/14/1997 | EP0772448A1 CYCLIC ANALOGS OF PTH AND PTHrP |
| 05/14/1997 | CN1149869A Substituted sulfonamides as selective beta3 agonists for treatment of diabetes and obesity |
| 05/14/1997 | CN1149830A Pyridylbisphosphonates for use as therapeutical agent |
| 05/13/1997 | US5629436 Use of N-arylmethylene ethylenediaminetriacetates N-arylmethylene iminodiacetates or N,N'-diarylmethylene ethylenediamineacetates against oxidative stress |
| 05/13/1997 | US5629338 Tannins and lipase inhibitors containing the same as active ingredients |
| 05/13/1997 | US5629327 Methods and compositions for inhibition of angiogenesis |
| 05/13/1997 | US5629315 Treatment of psoriasis, asthma,osteoporosis, alcoholic hepatitis, and premature labor |
| 05/13/1997 | US5629311 Substituted cyclohexanol esters their use for treating diseases and pharmaceutical preparations |
| 05/13/1997 | US5629295 Steroidal glycosides for treating hypercholesterolemia |
| 05/13/1997 | CA2033183C Water-soluble vitamin a preparations for application to the skin |
| 05/09/1997 | WO1997016455A1 Sugar-substituted 2-azetidinones useful as hypocholesterolemic a gents |
| 05/09/1997 | WO1997016442A1 Substituted pyridyl pyrroles, compositions containing such compounds and methods of use |
| 05/09/1997 | WO1997016434A1 (-) cis-6(s)-phenyl-5(r)[4-(2-pyrrolidin-1-ylethoxy)phenyl]-5,6,7,8-tetrahydronaphthalen-2-ol d-tartrate |
| 05/09/1997 | WO1997016432A1 Processes and intermediates for preparing 1-(2-[2-isoxazol-3-ylbenzofuran-5-yloxy]ethylamino)-3-phenoxy-2(s)-ol |
| 05/09/1997 | WO1997016430A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 05/09/1997 | WO1997016189A1 Combination therapy for the treatment of diabetes and obesity |
| 05/09/1997 | WO1997016185A2 A pharmaceutical composition for the treatment of autoimmune diseases |
| 05/09/1997 | WO1996034885A3 Biologically active peptide fragments of ob protein |
| 05/09/1997 | CA2234641A1 Hexahydro-5-imino-1,4-heteroazepine derivatives as inhibitors of nitric oxide synthases |
| 05/09/1997 | CA2234081A1 Processes and intermediates for preparing 1-(2-[2-isoxazol-3-ylbenzofuran-5-yloxy]ethylamino)-3-phenoxy-2(s)-ol |
| 05/07/1997 | EP0771818A2 Biotin derivatives |
| 05/07/1997 | EP0771813A1 Alkylxanthine phosphonates and alkylxanthine phosphine oxydes and their use as medicines |
| 05/07/1997 | EP0771795A1 New glycomimetics as Selectin antagonists, and anti-imflammation pharmaceutical compositions |
| 05/07/1997 | EP0771790A1 Process for preparing 1-substituted pyrrole-3-carboxylic acid derivatives |
| 05/07/1997 | EP0771788A2 Substituted sulphonimidamides, method for their preparation, their use as medicament or diagnostic and medicament containing them |
| 05/07/1997 | EP0771198A1 Dihydro-2,3-benzodiazepine derivatives |
| 05/07/1997 | EP0771194A1 Use of droloxifene for the treatment of cardiovascular diseases |
| 05/07/1997 | EP0660676B1 Novel compositions |
| 05/07/1997 | EP0238553B1 Method of treating catabolic dysfunction |
| 05/07/1997 | CN1149295A Tricyclic Dicarbonyl derivatives |
| 05/07/1997 | CN1149288A Vitamin-D amide derivatives |
| 05/07/1997 | CN1149046A New substituted 2,2-dimethyl-omega-phenoxyalkanoic acids and esters, process for their preparation and pharmaceutical compositions containing them |
| 05/07/1997 | CN1148984A Process for preparing pharmaceutical formulation containing insulin analog |
| 05/07/1997 | CN1148982A Sikang Shennong Yangsheng Health-care pellet |
| 05/06/1997 | US5627205 Substituted phenoxyisobutyric acids and esters |
| 05/06/1997 | US5627182 δ-amino-γ-hydroxy-ω-aryl-alkanoic acid amides |
| 05/06/1997 | US5627176 Substituted azetidinone compounds useful as hypocholesterolemic agents |
| 05/06/1997 | US5627170 Phosphonic acid compound containing heterocyclic substituents, pharmaceutical composition contains same and a method of treating calcium metabolism disturbance |
| 05/06/1997 | US5627157 α-glycosyl hesperidin and its uses |
| 05/06/1997 | US5627050 Bone-related sulfatase-like protein and process for its production |
| 05/06/1997 | US5626904 Salt product and a method for the preparation thereof |
| 05/06/1997 | US5626860 Treatment of diabetes and reduction of fat stores |
| 05/03/1997 | CA2189222A1 Alkylxanthine phosphonates and alkylxanthine phosphine oxides and their use as pharmaceuticals |
| 05/02/1997 | EP0770385A1 Use of astaxanthin for the treatment of stress |
| 05/02/1997 | EP0770087A1 Human elastase iv |
| 05/02/1997 | EP0770082A1 Dioxo-thiopyrano-pyridine carboxylic acid derivatives and their use as medicaments |
| 05/02/1997 | EP0770068A1 Conformationally rigid bicyclic and adamantane derivatives useful as alpha 2-adrenergic blocking agents |
| 05/02/1997 | EP0769960A1 Pharmaceutical compositions containing a bile salt and a buffer for increased bioavailability of an active compound |
| 05/02/1997 | EP0769950A1 Method and compound for the treatment of hair loss |
| 05/02/1997 | EP0769947A1 Indolinone compounds for the treatment of disease |
| 05/02/1997 | EP0769941A1 Use of droloxifene for the treatment of prostatic diseases, endometriosis and obesity |
| 05/02/1997 | EP0769917A1 Nervonic acid compositions |
| 05/01/1997 | WO1997015671A1 Luminal cholecystokinin-releasing factor |
| 05/01/1997 | WO1997015592A1 Novel human cysteine protease |
| 05/01/1997 | WO1997015574A1 Polymorphic forms of a growth hormone secretagogue |
| 05/01/1997 | WO1997015567A1 5-membered heterocycles, pharmaceutical agents containing said compounds and the use thereof and methods of producing them |
| 05/01/1997 | WO1997015556A1 3-spiro-indolin-2-one derivatives as vasopressin and/or oxytocin receptor ligands |
| 05/01/1997 | WO1997015318A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 05/01/1997 | WO1997015310A1 In vitro growth of functional islets of langerhans and in vivo uses thereof |
| 05/01/1997 | WO1997015302A1 Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use |
| 05/01/1997 | WO1997012527A3 Use of threonine for the treatment of phenylketonuria |
| 05/01/1997 | CA2238940A1 Luminal cholecystokinin-releasing factor |
| 05/01/1997 | CA2235756A1 Peptide inhibitors of a phosphotyrosine-binding domain containing protein |
| 05/01/1997 | CA2235575A1 Novel human cysteine protease |
| 05/01/1997 | CA2235509A1 In vitro growth of functional islets of langerhans and in vivo uses thereof |
| 05/01/1997 | CA2232336A1 Pharmaceutical compositions of levo-enantiomers of medetomidine derivatives and their use |
| 05/01/1997 | CA2229617A1 5-membered heterocycles, medicaments containing these compounds, their use and processes for their preparation |
| 05/01/1997 | CA2188381A1 Glycomimetics as selectin antagonists and pharmaceuticals having antiin flammatory activity |
| 04/30/1997 | CN1148854A Tropane-z-aldoxine derivatives and preparation process and use thereof |
| 04/30/1997 | CN1148811A Compound having antihypertensive, cardioprotective, anti-ischemic and antilipolytic functions |
| 04/30/1997 | CN1148590A Sulfuryl or sulfinyl benzoyl guanidine derivative |
| 04/30/1997 | CN1148492A Treatment for arteriosclerosis and vitiligoidea |
| 04/30/1997 | CN1034733C Spiro piperidines and homologs which promote release of growth hormone |